Experimental drug NU-9 -- a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS) -- improves neuron health in animal models of Alzheimer's disease, according to a new study.
from All Top News -- ScienceDaily https://ift.tt/5KgVmM0
Here different kind of articles available for people, simple and easy tips related to different topics.
No comments:
Post a Comment